The technical experts are reviewing Moderna Inc.’s COVID-19 vaccine for possible emergency use listing by WHO. The TAG (Technical Advisory Group) will review the COVID-19 vaccine candidate by the US drugmaker and the results are expected in four days.
Amid this positive news French drug make Sanofi SA has come forward to manufacture and package required doses of Moderna’s COVID-19 vaccine in the U.S. The company has signed the contract which runs through April 2022 that states that Sanofi SA would fill vials and finish packaging of Moderna’s COVID-19 vaccines for the U.S. supply.
So far, WHO has approved COVID-19 vaccines made by Pfizer, AstraZeneca, and Johnson & for emergency listing use. This serves as a signal of efficacy and safety to national regulatory authorities.